Muller & Phipps (India) is engaged in marketing of over the counter medical preparation and home care products.Product Profile: a) Cavisan - Medicated Dental Cream b) Cavifast - Medicated Dental Cream c) Cavisan - Gum Astringent d) Nixoderm
Muller and Phipps India Limited has announced its financial results for the quarter ended June 30, 2025. For the standalone results, the company reported a net income from operations of 1.99 Cr and a net profit after tax of 0.70 Cr. On a consolidated basis, the total income was 1.99...
Muller and Phipps India Limited has announced a certification from its Registrar and Share Transfer Agent confirming that all securities received for dematerialisation during the quarter were processed—accepted or rejected—and listed on the relevant stock exchanges. The certificates were duly verified, mutilated, and cancelled, with ownership records updated promptly in...
Muller and Phipps India Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company reported total income from operations at Rs. 176.94 lakh for the quarter and Rs. 619.93 lakh for the year. It recorded a net loss after tax of Rs....
Muller and Phipps India Limited has submitted its Annual Secretarial Compliance Report confirming adherence to all applicable statutory provisions and corporate governance practices for the financial year ended March 31, 2025. The company maintains two subsidiaries, with no change in statutory auditors due to resignation. All required policies, disclosures, and...
